Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.440
-0.020 (-1.37%)
At close: Mar 18, 2026, 4:00 PM EDT
1.410
-0.030 (-2.06%)
After-hours: Mar 18, 2026, 7:51 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $54.17 million as of March 18, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
54.17M
Enterprise Value
-66.53M
1-Year Change
-22.17%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $54.17M, a decrease of -90.38%. That is a compound annual growth rate of -67.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 54.93M | -9.70% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 58.72M |
| Entera Bio | 58.24M |
| ImmuCell | 57.62M |
| MAIA Biotechnology | 56.66M |
| Radiopharm Theranostics | 56.12M |
| Instil Bio | 56.02M |
| OS Therapies | 54.58M |
| Lipocine | 53.58M |